Osteoboost Health

What it does

Osteoboost Health is a medtech company offering the first and only FDA-cleared, drug-free prescription treatment for low bone density. The company provides a comprehensive platform addressing osteoporosis through an at-home device clinically proven to significantly slow vertebral bone loss. Inspired by advanced research, Osteoboost introduces a science-backed solution aimed at improving bone health for a large population affected by osteopenia and osteoporosis. The company’s Digital Care Program integrates therapy with reimbursable remote monitoring, enhancing patient engagement and care management. Osteoboost’s innovative approach, recognized as an FDA Breakthrough Device with De Novo approval, is positioned to transform the standard of care in bone health by providing an effective, non-pharmaceutical alternative. The acquisition of a specialized osteoporosis exercise program further strengthens its comprehensive treatment offering. Osteoboost’s technology and care model represent a significant advancement in addressing bone density loss and osteoporosis management.